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Abstract. 
 
Dysregulation of calcium signaling has been 
causally implicated in brain aging and Alzheimer’s dis-
ease. Mutations in the presenilin genes (
 
PS1
 
, 
 
PS2
 
), the 
leading cause of autosomal dominant familial Alzhei-
mer’s disease (FAD), cause highly speciﬁc alterations
in intracellular calcium signaling pathways that may 
contribute to the neurodegenerative and pathological 
lesions of the disease. To elucidate the cellular mecha-
nisms underlying these disturbances, we studied cal-
cium signaling in ﬁbroblasts isolated from mutant 
 
PS1
 
 
knockin mice. Mutant 
 
PS1
 
 knockin cells exhibited a 
marked potentiation in the amplitude of calcium tran-
sients evoked by agonist stimulation. These cells also 
showed signiﬁcant impairments in capacitative calcium 
entry (CCE, also known as store-operated calcium en-
try), an important cellular signaling pathway wherein 
depletion of intracellular calcium stores triggers inﬂux 
of extracellular calcium into the cytosol. Notably, deﬁ-
cits in CCE were evident after agonist stimulation, but 
not if intracellular calcium stores were completely de-
pleted with thapsigargin. Treatment with ionomycin 
and thapsigargin revealed that calcium levels within the 
ER were signiﬁcantly increased in mutant 
 
PS1
 
 knockin 
cells. Collectively, our ﬁndings suggest that the overﬁll-
ing of calcium stores represents the fundamental cellu-
lar defect underlying the alterations in calcium signal-
ing conferred by presenilin mutations.
Key words: Alzheimer’s disease • endoplasmic reticu-
lum • phosphoinositide signaling • store-operated cal-
cium channel • store-operated calcium entry
 
Introduction
 
Alzheimer’s disease (AD)
 
1
 
 is the leading cause of age-
related dementia (Selkoe, 1999). Certain familial forms of
AD (FAD) are characterized by an autosomal-dominant
inheritance pattern and a tragically early age of onset, and
most of these have been linked to mutations in the two
presenilin genes (
 
PS1, PS2
 
). The 
 
PS1 
 
and 
 
PS2 
 
genes en-
code highly conserved, polytopic integral membrane pro-
teins that are widely expressed not only within the central
nervous system (Cribbs et al., 1996), but also in many pe-
ripheral tissues (Sherrington et al., 1995). Intracellularly,
in both neural and nonneuronal cells, the presenilins are
localized predominantly to the ER (Cook et al., 1996).
The precise mechanisms by which presenilin mutations
lead to AD neurodegeneration are currently unresolved.
It is well established that presenilin mutations lead to in-
creased production of the longer species of 
 
b
 
-amyloid
(A
 
b
 
) from the A
 
b
 
 precursor protein (APP; Scheuner et
al., 1996). APP mismetabolism, however, need not repre-
sent the exclusive or most primary consequence of presen-
ilin mutations. It remains possible that other pathological
effects of presenilin mutations upstream of and/or inde-
pendent of A
 
b
 
 generation may also contribute to the mo-
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lecular and cellular changes characterizing AD neurode-
generation.
Mounting evidence has established that presenilin muta-
tions confer highly specific alterations in intracellular cal-
cium signaling pathways. For instance, a potentiation of
inositol 1,4,5-trisphosphate (InsP
 
3
 
)-mediated calcium sig-
nals has been documented in an array of experimental sys-
tems expressing 
 
PS1
 
 mutations, ranging from 
 
Xenopus
 
 oo-
cytes to transgenic animals (Guo et al., 1996, 1998, 1999;
Begley et al., 1999; Leissring et al., 1999a,b). Similar alter-
ations have also been observed in studies of human fibro-
blasts harboring FAD mutations (Ito et al., 1994; Gibson
et al., 1996; Etcheberrigaray et al., 1998). The calcium sig-
naling changes in FAD fibroblasts are highly selective and
specific for the disease, being present in affected individu-
als, but not in unaffected family members (Etcheberriga-
ray et al., 1998). Moreover, mutations in 
 
PS2 
 
produce al-
terations in calcium signaling indistinguishable from 
 
PS1
 
mutations (Leissring et al., 1999a,b), providing further
support that these changes represent a common patho-
genic feature of all FAD-linked presenilin mutations.
Several lines of evidence suggest that the dysregulation
of calcium signaling conferred by presenilin mutations
plays a causal role in the pathogenesis of FAD, underlying
both the neuronal degeneration and the hallmark patho-
logical features of the disease. For instance, elevated levels
of cytosolic calcium ([Ca
 
2
 
1
 
]
 
i
 
) in cultured cells can modu-
late the processing of APP and thereby increase A
 
b
 
 pro-
duction (Querfurth and Selkoe, 1994). This underscores
the likelihood that calcium dysregulation is at least one
cause of increased A
 
b
 
 production, and thus possibly con-
tributes to plaque formation. Furthermore, increased
[Ca
 
2
 
1
 
]
 
i
 
 has also been shown to increase hyperphosphoryla-
tion of tau (Mattson et al., 1991). Finally, altered calcium
homeostasis is centrally involved in the increased suscepti-
bility to cell death conferred by 
 
PS1
 
 mutations (Guo et al.,
1996, 1998, 1999; Mattson et al., 2000).
Despite the likely involvement of calcium disturbances
in the pathogenesis of FAD, very little is known about the
precise cellular mechanisms by which presenilin mutations
alter calcium signaling pathways. To address this issue, we
studied calcium signaling in fibroblasts from homozygous
mutant 
 
PS1
 
 knockin (KI) mice. In these genetically al-
tered mice, the endogenous mouse 
 
PS1
 
 gene has been re-
placed by the human counterpart containing the FAD-
linked mutation,
 
 PS1
 
M146V
 
 (Guo et al., 1999). This model
possesses many advantages over other experimental para-
digms, since the mutant human PS1 protein is expressed to
physiological levels, and the endogenous tissue and cellu-
lar expression pattern is maintained. Hence, concerns
about protein overexpression artifacts, ectopic expression,
or confounding influences of the wild-type protein are ob-
viated. Here, we demonstrate that agonist-evoked calcium
signals are markedly potentiated in the 
 
PS1
 
M146V
 
-KI fibro-
blasts. In addition, we report the novel finding that
 
PS1
 
M146V
 
-KI cells show deficits in capacitative calcium en-
try (CCE), i.e., the influx of extracellular calcium triggered
by depletion of intracellular calcium stores. Finally, we
provide evidence that both of these alterations are attrib-
utable to an abnormal elevation of ER calcium stores in
the mutant cells. Thus, these findings provide a novel cel-
lular mechanism to account for the calcium signaling alter-
 
ations conferred by presenilin mutations, which could lead
to the development of novel therapeutics for presenilin-
associated FAD.
 
Materials and Methods
 
Cell Culture
 
The derivation and characterization of the 
 
PS1
 
M146V
 
-KI mice has been de-
scribed elsewhere (Guo et al., 1999). To isolate fibroblasts, snips of tail
from neonatal homozygous 
 
PS1
 
M146V
 
-KI animals and controls were
washed with 70% ethanol, minced in CMF (Ca
 
2
 
1
 
- and Mg
 
2
 
1
 
-free HBSS),
and incubated for 30 min at 37
 
8
 
C in 2.5 ml of TCH solution (0.125%
trypsin, 0.5 mM EDTA and 1 mg/ml collagenase Type V (Sigma Chemical
Co.) in HBSS. After quenching the reaction by addition of DME supple-
mented with 20% FBS, the supernatant was removed and spun at 225 
 
g
 
for 5 min, and the pelleted cells were resuspended in DME/20% FBS.
Cells were maintained at 37
 
8
 
C in a 5% CO
 
2
 
 atmosphere. For calcium im-
aging experiments, P1-P4 cultures were plated onto glass-bottomed 6-cm
petri dishes (MatTek Corp.) and grown to near confluency. 1–2 h before
imaging, cells were loaded for 45 min at room temperature with 5 
 
m
 
M
Fura 2-AM supplemented with pluronic acid F-127 (Molecular Probes) in
Hepes-buffered control solution (HCSS) containing 120 mM NaCl, 5.4
mM KCl, 0.8 mM MgCl
 
2
 
, 2 mM CaCl
 
2
 
, 15 mM glucose, 20 mM Hepes, pH
7.3, and 0.5% phenol red (calcium-deficient HCSS contained 1 mM
EGTA and no CaCl
 
2
 
). Cells were washed three times with HCSS and al-
lowed to incubate for at least 30 min before imaging. All reagents were
purchased from Life Technologies, Inc. unless otherwise noted.
 
Calcium Imaging
 
Measurements of [Ca
 
2
 
1
 
]
 
i
 
 were obtained using the InCyt 
 
Im
 
2™ Ratio Imag-
ing System (Intracellular Imaging Inc.) using excitation at 340 and 380 nm.
The system was calibrated using stock solutions containing either no cal-
cium (0 calcium plus 1 mM EGTA) or a saturating level of calcium (1 mM)
using the formula [Ca
 
2
 
1
 
]
 
i
 
 
 
5 
 
K
 
d
 
(225) [(R
 
2
 
Rmin)/(Rmax
 
2
 
R)] (Fo/Fs).
Drugs were added by superfusion via a peristaltic pump and removed by
vacuum. All experiments were performed using fibroblasts harvested
from at least three different animals (
 
n
 
 5 
 
5–28 cells per experiment).
Quantitative data were analyzed by one-way ANOVA and are expressed
as mean 
 
6 
 
SEM.
 
Results
 
Potentiation of Agonist-evoked Calcium Signals in 
Mutant PS1 Knockin Cells
 
We studied calcium signals in fibroblasts isolated from
neonatal mutant 
 
PS1
 
 KI mice and controls using the cyto-
solic calcium indicator Fura-2 AM. To activate the phos-
phoinositide/calcium signaling cascade, cells were stimu-
lated with the cell surface receptor agonists, bradykinin (BK;
Fig. 1) or bombesin (data not shown). In control fibro-
blasts, BK stimulation evoked calcium signals with two
characteristic phases: a transient rise in [Ca
 
2
 
1
 
]
 
i
 
 lasting sec-
onds, followed by a sustained phase of elevated [Ca
 
2
 
1
 
]
 
i
 
lasting several minutes (Fig. 1 a).
Calcium signals in 
 
PS1
 
M146V
 
-KI fibroblasts differed from
controls in several salient respects. First, the rate of rise of
the calcium signal was significantly increased (Fig. 1, a and
b, inset). Second, the peak of the transient phase was sig-
nificantly potentiated (Fig 1, a and b). Finally, the sustained
phase of elevated [Ca
 
2
 
1
 
]
 
i
 
 present in control cells was virtu-
ally absent in the mutant fibroblasts (Fig. 1, a and b).
 
Impaired Capacitative Calcium Entry in Mutant PS1 
Knockin Cells
 
The sustained elevation of [Ca
 
2
 
1
 
]
 
i
 
 in control cells resem- 
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bles CCE, in which depletion of ER calcium stores triggers
the influx of extracellular calcium through store-operated
calcium channels (SOCCs; Lewis, 1999). To determine
whether the sustained phase resulted from calcium influx,
we stimulated cells with BK in calcium-deficient medium.
Removal of extracellular calcium abolished the sustained
phase in control cells, but had little effect on the calcium
signal in 
 
PS1
 
M146V
 
-KI cells, indicating that the sustained
phase of elevated [Ca
 
2
 
1
 
]
 
i
 
 in control cells reflects calcium
influx (compare Fig. 1, a and c). Notably, the initial cal-
cium transients in both control and 
 
PS1
 
M146V
 
-KI cells, which
reflect calcium release from intracellular stores, were re-
latively unaffected by removal of extracellular calcium
(compare Fig. 1, a and c). Therefore, the potentiation of
the initial calcium transient seen in 
 
PS1
 
M146V
 
-KI cells is at-
tributable to increased release of calcium from intracellu-
lar stores rather than calcium influx.
To determine if the sustained calcium phase reflected
CCE, we treated control cells with SKF-96365, an agent
known to block CCE through SOCCs (Merritt et al.,
1990). As illustrated in Fig. 1 d, SKF-96365 treatment
eliminated the sustained phase of [Ca
 
2
 
1
 
]
 
i
 
 in control cells
stimulated with BK in calcium-containing medium. Collec-
tively, these data indicate that the sustained phase of ele-
vated [Ca
 
2
 
1
 
]
 
i
 
 in control cells is CCE, and that CCE is dis-
rupted in cells harboring a mutation in 
 
PS1
 
.
To quantify the magnitude of CCE after agonist stimu-
lation, cells were initially stimulated with BK in calcium-
deficient medium. Subsequently, after the initial calcium
transients had returned to baseline, the calcium-deficient
medium was replaced with medium containing 2 mM cal-
cium (Fig. 2 a). Relative to controls, the magnitude of
CCE upon calcium readdition was significantly reduced in
 
PS1
 
M146V
 
-KI cells after stimulation with 50 nM BK (Fig. 2,
a and b). Intriguingly, in similar experiments using higher
concentrations of BK (5 
 
m
 
M), the deficits in CCE in
 
PS1
 
M146V
 
-KI cells, though still present, were significantly
attenuated (see Fig. 3). Furthermore, no differences in
CCE were observed after complete depletion of calcium
stores with thapsigargin (TG; Figs. 2, c and d, and 3). Thus,
as illustrated in Fig. 3, the magnitude of the deficits in
CCE in 
 
PS1
 
M146V
 
-KI cells varied according to the degree
and type of stimulation, with weak agonist stimulation
eliciting the greatest deficits and complete store depletion
eliciting no deficits whatsoever.
 
Elevated Calcium-Store Content in Mutant PS1 
Knockin Mice
 
The preceding results suggested that the 
 
PS1
 
M146V
 
-KI cells
possess functional SOCCs, but are impaired in their ability
to trigger CCE when weakly stimulated. Since the trigger
for CCE is the depletion of intracellular calcium stores, we
Figure 1. Agonist-evoked calcium signals are altered in
PS1M146V-KI fibroblasts: evidence for impaired capacitative cal-
cium entry. a, Typical traces showing calcium signals induced by
50 nM BK. b, Quantitative data from n 5 11 experiments show-
ing mean basal [Ca21]i, peak BK-evoked [Ca21]i, and [Ca21]i 5
min after agonist stimulation. Cytosolic calcium signals in control
cells contain two phases: a transient rise in [Ca21]i followed by a
sustained elevation of [Ca21]i lasting many minutes. Note the ab-
sence of the sustained phase in the PS1M146V-KI fibroblasts. The
inset shows quantitative data for the rates of rise of the initial cal-
cium transients. c, Representative calcium signals evoked by 50
nM BK in calcium-deficient medium. Note that control cells lack
the sustained phase of elevated [Ca21]i seen when extracellular
calcium is present, whereas PS1M146V-KI are relatively unchanged
(see a). d, Typical BK-evoked calcium signals in control cells in-
cubated in calcium-containing medium with or without SFK-
96365 (10 mM). Note that SKF-96365 reduces the sustained ele-
vation of [Ca21]i normally seen in control cells. *P , 0.01.
Figure 2. Capacitative calcium entry is impaired in PS1M146V-KI
fibroblasts after weak agonist stimulation, but not complete de-
pletion of calcium stores. a, Representative calcium signals
evoked by addition of 50 nM BK in calcium deficient medium,
followed by the readdition of 2 mM extracellular calcium. b,
Quantitative data from n 5 7 experiments showing basal [Ca21]i,
peak BK-evoked [Ca21]i, and peak [Ca21]i 30 s after readdition of
extracellular calcium. The inset shows quantitative data for the
rates of rise of the initial calcium transients. c, Representative
calcium signals after the addition of 1 mM TG in calcium-defi-
cient medium, followed by the readdition of 2 mM extracellular
calcium. d, Quantitative data from n 5 9 experiments showing
basal [Ca21]i, peak TG-evoked [Ca21]i, and peak [Ca21]i after re-
addition of extracellular calcium. *P , 0.01.The Journal of Cell Biology, Volume 149, 2000 796
hypothesized that CCE is impaired in PS1M146V-KI cells
because their ER calcium levels are abnormally elevated.
On this view, weak agonist stimulation, which elicits only a
transient release of ER calcium through rapidly inactivat-
ing InsP3 receptors (Parekh et al., 1997), fails to deplete
stores in the PS1M146V-KI cells to the threshold required
for CCE activation (see Fig. 5). To test this idea, the intra-
cellular calcium stores of resting cells were released by
treatment with TG or ionomycin in the nominal absence
of extracellular calcium (Fig. 4). The TG-releasable cal-
cium pool was significantly larger in PS1M146V-KI relative
to controls, as indicated by increases in both the peak
value of TG-evoked calcium transients (Fig. 4, a and b)
and in their rate of rise (1.67 6 0.12 nM s21 versus 1.11 6
0.11 nM s21, respectively, P , 0.01). Similar results were
obtained when cells were treated with the calcium iono-
phore ionomycin in calcium-deficient medium (Fig 4, c
and d). These data indicate that intracellular calcium
stores, including the ER, are increased in cells from
PS1M146V-KI mice. Collectively, our results suggest that the
potentiation of calcium transients and absence of CCE ob-
served in mutant PS1M146V-KI cells are attributable to in-
creased ER calcium levels.
Discussion
In this study we investigated calcium signaling in fibro-
blasts from KI mice harboring a PS1 mutation linked to
FAD. Relative to controls, cytosolic calcium signals from
PS1M146V-KI fibroblasts exhibited a significant potentia-
tion in calcium released by agonist activation of the phos-
phoinositide signaling pathway. In addition, KI cells ex-
hibited deficits in CCE evoked by agonist stimulation, but
not by complete depletion of ER calcium stores. We con-
clude that both of these alterations are attributable to
the elevation of ER calcium content in PS1M146V-KI fibro-
blasts.
The agonist-evoked calcium signals in PS1M146V-KI fi-
broblasts are virtually indistinguishable from comparable
experiments with human fibroblasts from FAD patients
harboring  PS1 mutations (compare our Fig. 1 a to Figure 1
a in Ito et al., 1994). Thus, the PS1M146V-KI animals faith-
fully mimic the calcium signaling changes seen in preseni-
lin-associated FAD. Importantly, since the mutant PS1
protein is expressed to physiological levels in these ani-
mals (Guo et al., 1999), none of the observed changes is at-
tributable to protein overexpression.
It is notable that, unlike human FAD fibroblasts, the
cells in this study were isolated from neonatal animals.
This suggests that the changes in calcium signaling in FAD
fibroblasts do not merely reflect secondary consequences
of AD pathogenesis, such as the accumulation of mito-
chondrial mutations during the lifetime of the individual
that have been shown to affect calcium signaling in cybrids
transformed with mitochondria from nonfamilial AD pa-
tients (Sheehan et al., 1997). Rather, our findings support
the hypothesis that altered calcium signaling is an early
and chronic consequence of PS1 mutations, one that may
play a causal role in the pathogenesis of FAD.
Although the present study was focused on fibroblasts,
the potentiation of calcium transients has been described
in neuronal cells from these same animals (Guo et al.,
1999; Leissring, M.A., Y. Akbari, and F.M. LaFerla,
manuscript in preparation). This strongly suggests that the
alterations in calcium signaling observed in peripheral
cells from FAD patients may be directly involved in FAD
neurodegeneration and memory loss (Disterhoft et al.,
1994; Mattson et al., 2000). This finding also supports the
use of fibroblasts as a model to study the pathological al-
terations in calcium signaling associated with presenilin
mutations.
Our results suggest that elevated ER calcium levels are
a fundamental cellular defect underlying the alterations in
calcium signaling conferred by presenilin mutations. As il-
lustrated in Fig. 5, we postulate that the higher levels of
ER calcium in PS1M146V-KI cells would impair CCE by
preventing agonist stimulation from depleting intracellular
calcium stores beyond the threshold level required to acti-
vate CCE. Moreover, this model provides a satisfactory
cellular mechanism to account for several observations
made in other experimental systems. First, elevated ER
calcium levels, by increasing the driving force on calcium
across the ER, would be expected to increase the ampli-
Figure 3. Comparison of ca-
pacitative calcium entry
evoked by weak or strong ag-
onist stimulation or TG
treatment. Data are shown
for experiments using the
protocol illustrated in Fig. 2,
in which cells were stimu-
lated with either 0.05 mM
BK, 5 mM BK, or 1 mM TG. Note that the data are expressed as
the increase in [Ca21]i relative to [Ca21]i 30 s before readdition of
extracellular calcium. *P , 0.01.
Figure 4. Intracellular calcium-store content is elevated in
PS1M146V-KI fibroblasts. a, Typical calcium signals evoked by
1 mM TG in calcium-deficient medium. b, Quantitative data
for n 5 7 experiments showing basal [Ca21]i and peak [Ca21]i in-
duced by TG treatment. c, Typical calcium signals evoked by 1
mM ionomycin (IONO) in calcium-deficient medium. d, Quanti-
tative data for n 5 9 experiments showing basal [Ca21]i and peak
[Ca21]i evoked by ionomycin treatment. *P , 0.01.Leissring et al. Presenilins and Capacitative Calcium Entry 797
tude of calcium release transients, as has been docu-
mented in many systems (Ito et al., 1994; Gibson et al.,
1996; Guo et al., 1996, 1998; Etcheberrigaray et al., 1998;
Leissring et al., 1999a,b). Second, an increased driving
force on calcium would also increase the rate of ER cal-
cium release (see Fig. 1 a) and would account for our ob-
servations in Xenopus oocytes that mutant PS1 increases
both the rate of calcium efflux and the average quantal
content of elementary calcium release events, the funda-
mental building blocks making up global calcium signals
(Mattson et al., 2000; Leissring, M.A., F.M. LaFerla, N.
Callamaras, and I. Parker, manuscript submitted for publi-
cation). Third, because ER calcium levels can modulate
the activity of IP3 receptors (Missiaen et al., 1992), ele-
vated calcium stores may also account for the increased
sensitivity of cells expressing presenilin mutations to IP3
stimulation. Finally, an overfilling of calcium stores may
also explain the interesting observation that long-term po-
tentiation is altered in mutant PS1 transgenic animals
(Parent et al., 1999; Mattson et al., 2000), raising the spec-
ter that calcium dysregulation may underlie the memory
impairments characterizing AD (Disterhoft et al., 1994).
The mechanism by which PS1 mutations elevate intra-
cellular calcium stores is not yet known. Intriguingly, how-
ever, FAD fibroblasts harboring PS1 mutations have ele-
vated levels of acylphosphatase, an enzyme that modulates
the activity of the ER calcium-ATPases responsible for
loading the ER (Liguri et al., 1996). Thus, overactivation
of ER calcium pumps may underlie the overfilling of cal-
cium stores. Future research into the molecular mecha-
nisms by which presenilin mutations increase ER calcium
levels could uncover novel targets for therapeutic inter-
vention.
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Figure 5. Model of the per-
turbations in calcium signal-
ing in PS1M146V-KI mice. a,
Schematic diagram illustrat-
ing changes in cytosolic cal-
cium signals after weak ago-
nist stimulation. b, Similar
diagram showing calcium lev-
els within the lumen of the
ER. After weak agonist stim-
ulation, luminal calcium lev-
els in control cells fall well
below the threshold level re-
quired for activation of CCE.
In contrast, weak agonist
stimulation barely triggers
CCE in PS1M146V-KI fibro-
blasts because luminal cal-
cium levels are abnormally
elevated.